Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Earnings Call: i 80 Gold steigert Produktion in Q2 2026, doch Verlust weitet sich aus (Investing.com DE) +++ I-80 GOLD Aktie +4,66%

MICROBOT Aktie

 >MICROBOT Aktienkurs 
1.495 EUR    (TradegateBSX)
Ask: 1.51 EUR / 3400 Stück
Bid: 1.48 EUR / 6500 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MICROBOT Aktie über LYNX handeln
>MICROBOT Performance
1 Woche: +6,8%
1 Monat: +1,9%
3 Monate: -9,0%
6 Monate: -9,1%
1 Jahr: -36,1%
laufendes Jahr: -8,2%
>MICROBOT Aktie
Name:  MICROBOT MEDICAL DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US59503A2042 / A2N5AS
Symbol/ Ticker:  CY9D (Frankfurt) / MBOT (NASDAQ)
Kürzel:  FRA:CY9D, ETR:CY9D, CY9D:GR, NASDAQ:MBOT
Index:  -
Profil:  Microbot Medical Inc. is a cutting-edge medical device company focused on enhancing healthcare through innovative technologies. The company's primary function is to develop micro-robotic medical solutions, with an emphasis on improving minimally inva..
>Volltext..
Marktkapitalisierung:  109.83 Mio. EUR
Unternehmenswert:  47.19 Mio. EUR
Umsatz:  0.09 Mio. EUR
EBITDA:  -13.84 Mio. EUR
Nettogewinn:  -12.3 Mio. EUR
Gewinn je Aktie:  -0.24 EUR
Schulden:  0.78 Mio. EUR
Liquide Mittel:  4.03 Mio. EUR
Operativer Cashflow:  -13.17 Mio. EUR
Bargeldquote:  21.7
Umsatzwachstum:  -
Gewinnwachstum:  -14%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel -
Suchwörter:  MICROBOT
Letzte Datenerhebung:  11.08.26
>MICROBOT Kennzahlen
Aktien/ Unternehmen:
Aktien: 67.16 Mio. St.
Frei handelbar: 90.86%
Rückkaufquote: -46.03%
Mitarbeiter: 43
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 301.32%
Bewertung:
KGV: -
KGV lG: -
KUV: 1112.56
KBV: 1.57
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -40%
Gewinnmarge: -13535.24%
Operative Marge: -15278.1%
Managementeffizenz:
Gesamtkaprendite: -26.09%
Eigenkaprendite: -27.58%
>MICROBOT Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Magen-Darm-Erkrankungen & -behandlung
 
11.08.26 - 16:21
Microbot Medical GAAP EPS of -$0.08 in-line, revenue of $0.24M misses by $0.16M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.26 - 14:33
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting (GlobeNewswire EN)
 
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies at the Society of Robotic Surgery Annual Meeting...
07.07.26 - 15:15
Microbot Medical sees 100%+ Q2 revenue growth as LIBERTY adoption grows (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.07.26 - 14:33
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 (GlobeNewswire EN)
 
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026...
30.06.26 - 14:33
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader (GlobeNewswire EN)
 
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina...
23.06.26 - 14:33
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System (GlobeNewswire EN)
 
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System...
16.06.26 - 15:24
Microbot Medical Aktie legt zu: Partnerschaft öffnet Zugang zum US-Behördenmarkt (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.06.26 - 14:33
Microbot Medical® Enters Into an Agreement to Expand Access for America′s Veteran and Military Patient Populations (GlobeNewswire EN)
 
Microbot Medical® Enters Into an Agreement to Expand Access for America's Veteran and Military Patient Populations...
09.06.26 - 15:48
Microbot Medical gewinnt Gesundheitsnetzwerk in Michigan als Kunden – Aktie legt zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.26 - 14:33
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System (GlobeNewswire EN)
 
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System...
02.06.26 - 14:33
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System (GlobeNewswire EN)
 
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System...
15.05.26 - 16:00
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu (GlobeNewswire EN)
 
Microbot to Hold Conference Call to Review Recent Progress; Executive Team to be Joined by Current LIBERTY Users, Dr. Charles Briggs and Dr. Zachary Bercu...
14.05.26 - 17:00
Microbot Medical plunges amid results, short report from White Diamond Research (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.05.26 - 15:54
Short-Report von White Diamond schickt Aktie von Microbot Medical auf Talfahrt (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
14.05.26 - 02:30
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
 
Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
30.04.26 - 14:33
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) (GlobeNewswire EN)
 
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in EMEA...
22.04.26 - 14:33
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® (GlobeNewswire EN)
 
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®...
15.04.26 - 20:30
Microbot Medical Begins Full U.S. Launch of LIBERTY System (Zacks)
 
MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth....
14.04.26 - 20:33
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire EN)
 
The presentation will be webcast live on April 15 at 10:15 a.m. ET. Continued Engagement with Healthcare Institutions Reflects Rising Momentum The presentation will be webcast live on April 15 at 10:15 a.m. ET. Continued Engagement with Healthcare Institutions Reflects Rising Momentum...
13.04.26 - 14:33
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (GlobeNewswire EN)
 
Successful Execution of the Limited Market Release (LMR) Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in Key Endovascular Procedures Successful Execution of the Limited Market Release (LMR) Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in Key Endovascular Procedures...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Werturteile sind nie Wahrheiten, sondern Wünsche, die meist erst wahr gemacht werden sollen. - Ludwig Marcuse
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!